| 51 |
8064320 | Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography. | 1994 May |
1 |
| 52 |
7907455 | Mechanism of action of cholinesterase inhibitors in Alzheimer's disease. | 1993 |
1 |
| 53 |
8248533 | Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. | 1993 |
1 |
| 54 |
1601960 | Determination of heptylphysostigmine in plasma by high-performance liquid chromatography with electrochemical detection. | 1992 Jan 17 |
1 |
| 55 |
1791534 | Intranasal absorption of physostigmine and arecoline. | 1991 Aug |
1 |
| 56 |
1904998 | A model for carbamate and organophosphate-induced emesis in humans. | 1991 Spring |
1 |
| 57 |
1967018 | Adrenergic-cholinergic imbalances: the physostigmine-syndrome is not antagonized by the MAO-A inhibitor brofaromine. | 1990 Nov |
1 |
| 58 |
2497488 | Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys. | 1989 |
1 |
| 59 |
2570433 | Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine. | 1989 |
1 |
| 60 |
2683549 | Central anticholinergic syndrome (CAS) in anesthesia and intensive care. | 1989 |
1 |
| 61 |
3069749 | Cortisol responses to cholinergic drugs in Alzheimer's disease. | 1988 Oct |
3 |
| 62 |
3074841 | Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex. | 1988 |
1 |
| 63 |
3150807 | Physostigmine enhances blood flow-metabolism ratio in neocortex. | 1988 Dec |
1 |
| 64 |
2821940 | Pharmacologic evaluation and structure activity relationships of a series of hemicholinium-3 (HC-3) analogs. | 1987 Jul |
1 |
| 65 |
3435078 | Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. | 1987 Dec |
2 |
| 66 |
3601008 | A comparison of the effects of two inhibitors on brain cholinesterase. | 1987 Jun |
2 |
| 67 |
3524957 | Clinical pharmacokinetics of cholinesterase inhibitors. | 1986 May-Jun |
1 |
| 68 |
3797688 | Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease. | 1986 |
1 |
| 69 |
3809224 | Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model. | 1986 Dec |
1 |
| 70 |
2580948 | Substance P in human plasma is degraded by dipeptidyl peptidase IV, not by cholinesterase. | 1985 May |
1 |
| 71 |
3980055 | Central cardiovascular effects of physostigmine in humans. | 1985 Jan-Feb |
1 |
| 72 |
3999598 | [Ocular myasthenia]. | 1985 Mar |
1 |
| 73 |
6143326 | Cholinergic modulation of stimulant-induced behavior. | 1984 Mar |
1 |
| 74 |
6470148 | Central cholinergic stimulation causes adrenal epinephrine release. | 1984 Sep |
1 |
| 75 |
6487203 | A cholinomimetic model of motion sickness and space adaptation syndrome. | 1984 Aug |
2 |
| 76 |
6511307 | A new simple method for determining the kinetic constants of inhibited acetylcholinesterase. | 1984 Sep-Oct |
1 |
| 77 |
6516793 | Perivascular cholinesterase and morphological blood-brain barrier function. | 1984 Dec |
1 |
| 78 |
6747844 | Presynaptic inhibitory effect of Met-enkephalin on [14C] acetylcholine release from the myenteric plexus and its interaction with muscarinic negative feedback inhibition. | 1984 Aug |
1 |
| 79 |
6347034 | Oral physostigmine and lecithin improve memory in Alzheimer disease. | 1983 May |
1 |
| 80 |
6840979 | Acute administration of individual optimal dose of physostigmine fails to improve mnesic performances in Alzheimers Presenile Dementia. | 1983 |
1 |
| 81 |
6752738 | A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease. | 1982 Summer |
1 |
| 82 |
7135153 | Alteration of ethanol-induced sleep latency by physostigmine in animals. | 1982 |
1 |
| 83 |
7217205 | Electron microscope localization of acetylcholinesterase and butyrylcholinesterase in the superior cervical ganglion of the cat. II. Preganglionically denervated ganglion. | 1981 Mar |
1 |
| 84 |
7298772 | Quantitative determination of the cholinesterase inhibitor physostigmine in brain tissue samples using reversed-phase high-performance liquid chromatography. | 1981 Oct 9 |
1 |
| 85 |
7188667 | Physostigmine-atropine solution fails to reverse diazepam sedation. | 1980 Jan |
1 |
| 86 |
445230 | The effects of periarterial nerve activation on coronary vessel tone in an isolated and perfused slab of beef ventricle. | 1979 Mar |
1 |
| 87 |
30564 | Physostigmine for cardiac and neurologic manifestations of phenothiazine poisoning. | 1978 Dec |
1 |
| 88 |
203742 | [Diagnosis and treatment of ocular myasthenia (author's transl)]. | 1977 Dec |
1 |
| 89 |
4343315 | Cholinergic and non-cholinergic transmission in the medial geniculate nucleus of the cat. | 1972 Oct |
1 |
| 90 |
5315359 | Distribution of cholinesterases in insects. | 1971 |
1 |
| 91 |
13525672 | The effect of enzyme inhibitors on the resting potential and on the ion distribution of the sartorius muscle of the frog. | 1958 May 20 |
1 |
| 92 |
19873399 | THE MECHANISM OF ENZYME-INHIBITOR-SUBSTRATE REACTIONS : ILLUSTRATED BY THE CHOLINESTERASE-PHYSOSTIGMINE-ACETYLCHOLINE SYSTEM. | 1944 Jul 20 |
5 |
| 93 |
19873367 | ZONE BEHAVIOR OF ENZYMES : ILLUSTRATED BY THE EFFECT OF DISSOCIATION CONSTANT AND DILUTION ON THE SYSTEM CHOLINESTERASE-PHYSOSTIGMINE. | 1943 Jul 20 |
1 |